A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia

Complex Operative Unit of Haematology, dell’Angelo Hospital and Santissimi Giovanni and Paolo Hospital, Mestre and Venice, Italy
Department of Medicine II, Schleswig-Holstein University Hospital, Kiel, Germany
Amgen Ltd, Uxbridge, UK
Oxford PharmaGenesis, Oxford, UK and
Amgen (Europe) GmbH, Zug, Switzerland
Amgen Ltd, Uxbridge, UK
Vol. 104 No. 10 (2019): October, 2019